Molecules and Cells

, Volume 35, Issue 3, pp 219–225 | Cite as

Regulatory effects of resveratrol on antioxidant enzymes: A mechanism of growth inhibition and apoptosis induction in cancer cells

  • Md. Asaduzzaman Khan
  • Han-chun ChenEmail author
  • Xin-xing Wan
  • Mousumi Tania
  • Ai-hua Xu
  • Fang-zhi Chen
  • Dian-zheng Zhang
Research Article


Resveratrol (RSV) is a natural polyphenol that is known as a powerful chemopreventive and chemotherapeutic anticancer molecule. This study focused on the effects of RSV on the activities and expression levels of antioxidant enzymes in the cancer cells. Prostate cancer PC-3 cells, hepatic cancer HepG2 cells, breast cancer MCF-7 cells and the non-cancerous HEK293T kidney epithelial cells were treated with a wide range of RSV concentrations (10-100 μM) for 24–72 h. Cell growth was estimated by trypan blue staining, activities of the antioxidant enzymes were measured spectrophotometrically, expression levels of the antioxidant enzymes were quantified by digitalizing the protein band intensities on Western blots, and the percentage of apoptotic cells was determined by flow cytometry. Treatment with a low concentration of RSV (25 μM) significantly increased superoxide dismutase (SOD) activity in PC-3, HepG2 and MCF-7 cells, but not in HEK293T cells. Catalase (CAT) activity was increased in HepG2 cells, but no effect was found on glutathione peroxidase (GPX) upon RSV treatment. RSV-induced SOD2 expression was observed in cancer cells, although the expression of SOD1, CAT and GPX1 was unaffected. Apoptosis increased upon RSV treatment of cancer cells, especially in PC-3 and HepG2 cells. Together, our data demonstrated that RSV inhibits cancer cell growth with minimal effects on non-cancerous cells. We postulate that the disproportional up-regulation of SOD, CAT and GPX expression and enzymatic activity in cancer cells results in the mitochondrial accumulation of H2O2, which in turn induces cancer cell apoptosis.


Apoptosis HepG2 cells MCF-7 cells PC-3 cells resveratrol superoxide dismutase 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Arsova-Sarafinovska, Z., Eken, A., Matevska, N., Erdem, O., Sayal, A., Savaser, A., Banev, S., Petrovski, D., Dzikova, S., Georgiev, V., et al. (2009). Increased oxidative/nitrosative stress and decreased antioxidant enzyme activities in prostate cancer. Clin. Biochem. 42, 1228–1235.PubMedCrossRefGoogle Scholar
  2. Bae, S., Lee, E.M., Cha, H.J., Kim, K., Yoon, Y., Lee, H., Kim, J., Kim, Y.J., Lee, H.G., Jeung, H.K., et al. (2011). Resveratrol alters microRNA expression profiles in A549 human non-small cell lung cancer cells. Mol. Cells 32, 243–249.PubMedCrossRefGoogle Scholar
  3. Benitez, D.A., Pozo-Guisado, E., Alvarez-Barrientos, A., Fernandez-Salguero, P.M., and Castellón, E.A. (2007). Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines. J. Androl. 28, 282–293.PubMedCrossRefGoogle Scholar
  4. Bishayee, A. (2009). Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials. Cancer Prev. Res. (Phila) 2, 409–418.CrossRefGoogle Scholar
  5. Bradford, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248–254.PubMedCrossRefGoogle Scholar
  6. Carbó, N., Costelli, P., Baccino, F.M., López-Soriano, F.J., and Argilés, J.M. (1999). Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model. Biochem. Biophys. Res. Commun. 254, 739–743.PubMedCrossRefGoogle Scholar
  7. Chen, Y., Tseng, S.H., Lai, H.S., and Chen, W.J. (2004). Resveratrol-induced cellular apoptosis and cell cycle arrest in neuroblastoma cells and antitumor effects on neuroblastoma in mice. Surgery 136, 57–66.PubMedCrossRefGoogle Scholar
  8. Chung-man Ho, J., Zheng, S., Comhair, S.A., Farver, C., and Erzurum, S.C. (2001). Differential expression of manganese superoxide dismutase and catalase in lung cancer. Cancer Res. 61, 8578–8585.PubMedGoogle Scholar
  9. De Craemer, D., Pauwels, M., Hautekeete, M., and Roels, F. (1993). Alterations of hepatocellular peroxisomes in patients with cancer. Catalase cytochemistry and morphometry. Cancer 71, 3851–3858.PubMedCrossRefGoogle Scholar
  10. Elchuri, S., Oberley, T.D., Qi, W., Eisenstein, R.S., Jackson Roberts, L., Van Remmen, H., Epstein, C.J., and Huang, T.T. (2005). CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene 24, 367–380.PubMedCrossRefGoogle Scholar
  11. Frémont, L., Belguendouz, L., and Delpal, S. (1999). Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to LDL oxidation and polyunsaturated fatty acids. Life Sci. 64, 2511–2521.PubMedCrossRefGoogle Scholar
  12. Giorgio, M., Migliaccio, E., Orsini, F., Paolucci, D., Moroni, M., Contursi, C., Pelliccia, G., Luzi, L., Minucci, S., Marcaccio, M., et al. (2005). Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 122, 221–233.PubMedCrossRefGoogle Scholar
  13. Giorgio, M., Trinei, M., Migliaccio, E., and Pelicci, P.G. (2007). Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals? Nat. Rev. Mol. Cell Biol. 8, 722–728.CrossRefGoogle Scholar
  14. Góth, L. (1991). A simple method for determination of serum catalase activity and revision of reference range. Clin. Chim. Acta 196, 143–151.PubMedCrossRefGoogle Scholar
  15. Graf, E., and Penniston, J.T. (1980). Method for determination of hydrogen peroxide, with its application illustrated by glucose assay. Clin. Chem. 26, 658–660.PubMedGoogle Scholar
  16. Harikumar, K.B., and Aggarwal, B.B. (2008). Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 7, 1020–1035.PubMedCrossRefGoogle Scholar
  17. Huang, X., and Zhu, H.L. (2011). Resveratrol and its analogues: promising antitumor agents. Anticancer Agents Med. Chem. 11, 479–490.PubMedCrossRefGoogle Scholar
  18. Jang, M., Cai, L., Udeani, G.O., Slowing, K.V., Thomas, C.F., Beecher, C.W., Fong, H.H., Farnsworth, N.R., Kinghorn, A.D., Mehta, R.G., et al. (1997). Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275, 218–220.PubMedCrossRefGoogle Scholar
  19. Jeon, S.H., Jae-Hoon Park, J.H., and Chang, S.G. (2007). Expression of antioxidant enzymes (catalase, superoxide dis-mutase, and glutathione peroxidase) in human bladder cancer. Korean J. Urol. 48, 921–926.CrossRefGoogle Scholar
  20. Kasapović, J., Pejić, S., Todorović, A., Stojiljković, V., and Pajović, S.B. (2008). Antioxidant status and lipid peroxidation in the blood of breast cancer patients of different ages. Cell Biochem. Funct. 26, 723–730.PubMedCrossRefGoogle Scholar
  21. Khan, M.A., Tania, M., Zhang, D.Z., and Chen, H.C. (2010). Antioxidant enzymes and cancer. Chin. J. Cancer Res. 22, 87–92.CrossRefGoogle Scholar
  22. Klaunig, J.E., and Kamendulis, L.M. (2004). The role of oxidative stress in carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 44, 239–267.PubMedCrossRefGoogle Scholar
  23. Kovacic, P., and Somanathan, R. (2010). Multifaceted approach to resveratrol bioactivity: focus on antioxidant action, cell signaling and safety. Oxid. Med. Cell Longev. 3, 86–100.PubMedCrossRefGoogle Scholar
  24. Kowaltowski, A.J., Castilho, R.F., and Vercesi, A.E. (2001). Mitochondrial permeability transition and oxidative stress. FEBS Lett. 495, 12–15.PubMedCrossRefGoogle Scholar
  25. Miller, N.J., and Rice-Evans, C.A. (1995). Antioxidant activity of resveratrol in red wine. Clin. Chem. 41, 1789.PubMedGoogle Scholar
  26. Mo, W., Xu, X., Xu, L., Wang, F., Ke, A., Wang, X., and Guo, C. (2012). Resveratrol inhibits proliferation and induces apoptosis through the hedgehog signaling pathway in pancreatic cancer cell. Pancreatology 11, 601–609.CrossRefGoogle Scholar
  27. Muqbil, I., Beck, F.W., Bao, B., Sarkar, F.H., Mohammad, R.M., Hadi, S.M., and Azmi, A.S. (2012). Old wine in a new bottle: the Warburg effect and anticancer mechanisms of resveratrol. Curr. Pharm. Des. 18, 1645–1654.PubMedCrossRefGoogle Scholar
  28. Nakata, R., Takahashi, S., and Inoue, H. (2012). Recent advances in the study on resveratrol. Biol. Pharm. Bull. 35, 273–279.PubMedCrossRefGoogle Scholar
  29. Park, C.E., Yun, H., Lee, E.B., Min, B.I., Bae, H., Choe, W., Kang, I., Kim, S.S., and Ha, J. (2010). The antioxidant effects of genistein are associated with AMP-activated protein kinase activation and PTEN induction in prostate cancer cells. J. Med. Food 13, 815–820.PubMedCrossRefGoogle Scholar
  30. Park, S.J., Ahmad, F., Philp, A., Baar, K., Williams, T., Luo, H., Ke, H., Rehmann, H., Taussig, R., Brown, A.L., et al. (2012). Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 148, 421–433.PubMedCrossRefGoogle Scholar
  31. Patel, K.R., Scott, E., Brown, V.A., Gescher, A.J., Steward, W.P., and Brown, K. (2011). Clinical trials of resveratrol. Ann. N. Y. Acad. Sci. 1215, 161–169.PubMedCrossRefGoogle Scholar
  32. Petit, E., Courtin, A., Kloosterboer, H.J., Rostène, W., Forgez, P., and Gompel, A. (2009). Progestins induce catalase activities in breast cancer cells through PRB isoform: correlation with cell growth inhibition. J. Steroid Biochem. Mol. Biol. 115, 153–160.PubMedCrossRefGoogle Scholar
  33. Robb, E.L., Page, M.M., Wiens, B.E., and Stuart, J.A. (2008). Molecular mechanisms of oxidative stress resistance induced by resveratrol: Specific and progressive induction of MnSOD. Biochem. Biophys. Res. Commun. 367, 406–412.PubMedCrossRefGoogle Scholar
  34. Rotruck, J.T., Pope, A.L., Ganther, H.E., Swanson, A.B., Hafeman, D.G., and Hoekstra, W.G. (1973). Selenium: biochemical role as a component of glutathione peroxidase. Science 179, 588–590.PubMedCrossRefGoogle Scholar
  35. Scarlatti, F., Maffei, R., Beau, I., Codogno, P., and Ghidoni, R. (2008). Role of non-canonical Beclin 1-independent autophagy in cell death induced by resveratrol in human breast cancer cells. Cell Death Differ. 15, 1318–1329.PubMedCrossRefGoogle Scholar
  36. Scott, E., Steward, W.P., Gescher, A.J., and Brown, K. (2012). Resveratrol in human cancer chemoprevention—choosing the ‘right’ dose. Mol. Nutr. Food Res. 56, 7–13.PubMedCrossRefGoogle Scholar
  37. Sengottuvelan, M., Deeptha, K., and Nalini, N. (2009). Resveratrol ameliorates DNA damage, prooxidant and antioxidant imbalance in 1,2-dimethylhydrazine induced rat colon carcinogenesis. Chem. Biol. Interact. 181, 193–201.PubMedCrossRefGoogle Scholar
  38. Sharma, A., Tripathi, M., Satyam, A., and Kumar, L. (2009). Study of antioxidant levels in patients with multiple myeloma. Leuk. Lymphoma 50, 809–815.PubMedCrossRefGoogle Scholar
  39. Sun, Y.I., Oberley, L.W., and Li, Y. (1988). A simple method for clinical assay of superoxide dismutase. Clin. Chem. 34, 497–500.PubMedGoogle Scholar
  40. Yu, J., and Kim, A.K. (2009). Effect of taurine on antioxidant enzyme system in B16F10 melanoma cells. Adv. Exp. Med. Biol. 643, 491–499.PubMedCrossRefGoogle Scholar
  41. Zhou, H.B., Chen, J.J., Wang, W.X., Cai, J.T., and Du, Q. (2005). Anticancer activity of resveratrol on implanted human primary gastric carcinoma cells in nude mice. World J. Gastroenterol. 11, 280–284.PubMedGoogle Scholar

Copyright information

© The Korean Society for Molecular and Cellular Biology and Springer Netherlands 2013

Authors and Affiliations

  • Md. Asaduzzaman Khan
    • 1
  • Han-chun Chen
    • 1
    Email author
  • Xin-xing Wan
    • 1
  • Mousumi Tania
    • 1
  • Ai-hua Xu
    • 1
  • Fang-zhi Chen
    • 2
  • Dian-zheng Zhang
    • 1
    • 3
  1. 1.Department of Biochemistry, School of Biological Science and TechnologyCentral South UniversityChangsha, HunanChina
  2. 2.Department of Urologythe Second Xiangya Hospital of Central South UniversityChangsha, HunanChina
  3. 3.Department of Biochemistry/Molecular BiologyPhiladelphia College of Osteopathic MedicinePhiladelphiaUSA

Personalised recommendations